HER2 testing in breast carcinoma: very low concordance rate between reference and local laboratories in Brazil.
Author(s): Wludarski SC, Lopes LF, Berto E Silva TR, Carvalho FM, Weiss LM, Bacchi CE
Publication: Appl Immunohistochem Mol Morphol, 2011, Vol. 19, Page 112-8
PubMed ID: 20930616 PubMed Review Paper? No
Purpose of Paper
Conclusion of Paper
Studies
-
Study Purpose
The purpose of this study was to compare HER2 IHC and FISH results for breast carcinoma specimens and to determine factors leading to discordant IHC results between reference and local laboratories.
Summary of Findings:
Out of 2000 specimens examined, FISH results were inconclusive for 218 specimens predominantly due to inadequate preservation of tissue. Overall concordance was 98.4% for HER2 positive and negative cases by IHC and FISH. Specimens found to be HER2 equivocal by IHC staining were negative (nonamplified) for HER-2 by FISH 69.8% of the time and positive (amplified) by FISH 30.2% of the time. Between the reference laboratory and local laboratories, HER2 immunostaining results were concordant 6.2%, 14.0%, 84.9%, and 43.8% of the time for scores of 0, 1+, 2+, and 3+, respectively. 27 of the 247 cases (10.9%) scored as 0 or 1+ (negative) by the reference laboratory were scored as 3+ (positive) by local laboratories, and an additional 173 of these cases (70.0%) were scored as 2+ (equivocal) by local laboratories. Of note, information regarding the antibodies used for HER2 IHC analysis was not provided by 55.8% of the local laboratories, while all specimens were analyzed with the SP3 antibody at the reference laboratory. Further, information about fixative and fixation time was not provided by 62.6% of the local laboratories.
Biospecimens
Preservative Types
- Formalin
Diagnoses:
- Neoplastic - Carcinoma
Platform:
Analyte Technology Platform Protein Immunohistochemistry DNA FISH Morphology Light microscopy Pre-analytical Factors:
Classification Pre-analytical Factor Value(s) Immunohistochemistry Specific Technology platform FISH
Immunohistochemistry Specific Targeted peptide/protein HER2
Immunohistochemistry Specific Type of antibody SP3
Unspecified
CB11
DAKO polyclonal
5A2
HercepTest
A0485
Unspecified polyclonal
TAB250
EP1045Y
HER-24
CBE1
10A7
FISH Specific Targeted nucleic acid HER2